The Roundup: Top Takeaways from Oaktree’s Quarterly Letters – June 2023 Edition
The Insight by Oaktree Capital
The Positive Prognosis for Life Sciences Lenders
In 2023, private lenders have often been able to secure higher coupons and stronger investor protections than they could in recent years. The market environment has become attractive for those direct lenders with available capital who were patient during the boom years. They may now be well positioned to benefit from the opportunities created by the withdrawal of the chastened bulls.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
